MEDIGENE PARTICIPATES AT UPCOMING CONFERENCES

On October 30, 2019 Medigene AG (FSE: MDG1, Prime Standard) reported its participation at the following upcoming scientific and investor conferences (Press release, MediGene, OCT 30, 2019, View Source [SID1234550138]). Medigene’s management and/or scientists will be available for one-on-one meetings at these events.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SITC (Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper)) 34th Annual Meeting
Date: 6 – 10 November 2019
Location: National Harbor, USA

BIO Europe
Date: 11 – 13 November 2019
Location: Hamburg, Germany

Jefferies London Healthcare Conference
Date: 20 – 21 November 2019
Location: London, UK

Cell Therapy Manufacturing & Gene Therapy Congress
Date: 3 – 6 December 2019
Location: Amsterdam, Netherlands

61st ASH (Free ASH Whitepaper) Annual Meeting & Exposition
Date: 7 – 10 December 2019
Location: Orlando, USA

ESMO Immuno-Oncology Congress 2019
Date: 11 – 14 December 2019
Location: Geneva, Switzerland